Emergency use authorization of abcellera-discovered bamlanivimab administered with etesevimab expanded by the fda to include post-exposure prophylaxis for the prevention of covid-19

Vancouver, british columbia--(business wire)---- $abcl #abcellera--eua of bamlanivimab administered with etesevimab expanded by the fda to include post-exposure prophylaxis for the prevention of covid-19
ABCL Ratings Summary
ABCL Quant Ranking